AlphaGrep UK
TWST icon

AlphaGrep UK’s Twist Bioscience TWST Stock Holding History

AlphaGrep UK’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$212K Sell
1,098
-1,132
-51% -$140K 0.06% 659
2026
Q2 		$229K Buy
+2,230
New +$145K 0.07% 633

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

AlphaGrep UK's TWST Position: Q3 2026 in Review

AlphaGrep UK reduced its Twist Bioscience (TWST) stake by 51% in Q3 2026, selling an estimated $140K and leaving 1,098 shares worth $212K. The position accounts for 0.06% of the portfolio, ranked #659.

AlphaGrep UK first reported a position in TWST in Q2 2026 and has held it in 2 quarters since. The position peaked at $229K in Q2 2026. 330 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • AlphaGrep UK held 1,098 shares of Twist Bioscience worth $212K as of Q3 2026.
  • AlphaGrep UK sold 1,132 Twist Bioscience shares in Q3 2026, an estimated $140K.
  • Twist Bioscience made up 0.06% of AlphaGrep UK's portfolio in Q3 2026, its #659 holding.
  • AlphaGrep UK first reported a position in Twist Bioscience in Q2 2026 and has held it in 2 quarters since.
  • AlphaGrep UK's Twist Bioscience position peaked at $229K in Q2 2026.
  • 330 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.